About Us
Science Programs
Pipeline
Clinical Trials
Careers
cONTACT
Resources
Corporate Presentation
Posters, PRESENTATIONS & Publications
MEDIA
Events
News & press releases
Investors
Overview
Stock Information
Analyst Coverage
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Financials & SEC FILINGS
Sec Filings
Quarterly Results
cORPORATE GOVERNANCE
Management Team
Board of Directors
Committee Composition
Governance Documents
News & Press Releases
Get up to speed with Rain!
Filter by year...
2022
2021
2020
2019
2018
Reset Filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
June
2
,
2021
Rain Therapeutics Announces Patient Referral Partnership for the Planned MDM2-Amplified Phase 2 Basket Trial of RAIN-32
Download PDf
May
27
,
2021
Rain Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
Download PDf
May
25
,
2021
Rain Therapeutics Reports First Quarter 2021 Financial Results and Highlights Recent Progress
Download PDf
May
20
,
2021
Rain Therapeutics Appoints Robert Doebele, M.D., Ph.D. as President
Download PDf
April
22
,
2021
Rain Therapeutics Announces Pricing of Initial Public Offering
Download PDf
April
13
,
2021
Rain Therapeutics Strengthens the Board of Directors and Scientific Advisory Board with Key Appointments of Leading Industry and Research Experts
Download PDf
April
7
,
2021
Rain Therapeutics Appoints Richard Bryce, MBChB, as Executive Vice President and Chief Medical Officer
Download PDf
October
26
,
2020
Rain Therapeutics Announces a Phase 1 Trial Update for the MDM2 Inhibitor, RAIN-32, at the 32nd EORTC-NCI-AACR Virtual Symposium
Download PDf
October
14
,
2020
Rain Therapeutics Announces Late-Breaker Oral Presentation at the 32nd EORTC-NCI-AACR Virtual Symposium
Download PDf
September
15
,
2020
Rain Therapeutics Announces Appointment of Robert Doebele, MD, PhD as Executive Vice President and Chief Scientific Officer
Download PDf
Previous
#
Next
